Therefore, in the current study, we analyzed the DNA methylation status of several genes that have 137 been implicated in CAD in young individuals (25-50 years) to understand the role of DNA 138 methylation in developing premature CAD. Study population and biochemical parameter measurement: 144 We performed a cross sectional study to examine the DNA methylation status of promoter and 145 gene body region of several genes associated with CAD in 42 healthy controls and 33 young CAD 146 subjects. CAD patients were recruited from All India Institute of Medical Sciences (AIIMS), New 147 Delhi following coronary angiography and the healthy controls were from the general population. 148 The study was undertaken in accordance with the Principles of the Helsinki Declaration and was where a single adenine base "A" was added to the 3' end of the library and another round of 186 AMPure bead based purification was performed. Methylated adapter ligation was performed on 187 the dA tailed DNA using ligation master mix provided in the kit. Purification after this step was 188 done immediately to avoid self-ligation of adapters. The quality of the end repaired and adapter 189 ligated libraries were checked using DNA 1000 kit in Bioanalyzer ( Supplementary Fig 3) .
190
Following methylated adapter ligation, the size increased to 200-300 bp as expected 191 ( Supplementary Fig 3) . fig 3) . The indexed libraries were quantified using Qubit
204
High sensitivity DNA kit (Qubit HS). All the indexed libraries were then diluted to 5 nM 205 concentration and combined into a single pool which was used for sequencing. about 6400 coordinates were reported in at least 2 samples ( Supplementary Table 3 ). Unpaired
228
Student's t-test was performed on these coordinates to identify the differentially methylated CpG 229 sites (p < 0.05). We found 260 such CpG sites, associated with 45 genes to be significantly (p-230 value < 0.05) differentially methylated between controls and CAD patients ( Supplementary Table   231 4). Further those CpG sites harboring significant differential methylation were mapped back to 232 their respective genomic locations using in-house PERL programme.
234
Results:
The demographic characteristics of the individuals included in the study are provided in Table 1 .
237
The average age of controls and cases were 40.7 and 42.1 years respectively indicating that 238 relatively young individuals were considered for this study.
239
Targeted bisulfite sequencing of 48 genes (details provided in Supplementary Table 1) Elevated blood glucose levels have been an important risk factor for CAD. We found that the 278 promoter region of the gene GCK (glucokinse), which plays a major role in converting glucose to 279 glucose 6 phosphate, is hypermethylated ( Figure 3A It is known that endothelial cells exposed to hyperglycemic conditions show decreased NO 287 production, increased levels of adhesion molecules accompanied by inflammation and also 288 increased levels of apoptosis (Funk, Yurdagul et al. 2012 ). This is also suggestive from our results 289 as we found hypermethylation in the promoter of endothelial nitric oxide synthase (eNOS) gene 290 responsible for NO production in the endothelial cells ( Figure 3C ) which could potentially lead to 291 reduced levels of NO and vasoconstriction in the arteries. We also observed hypomethylation in 292 the 5' UTR region of cell adhesion molecule ICAM2 (cg62086376) implying increased adhesion 293 and aggregation processes occurring during atherosclerosis ( Figure 3D ).
294
It is also known that endothelial dysfunction is responsible for inducing cell apoptosis via Figure 5B ). 320 We probed into the methylation status of the genes causing extracellular matrix turnover of the In the current study, we interrogated DNA methylation status of candidate genes involved in 351 cholesterol biosynthesis and metabolism, endothelial dysfunction, inflammation and apoptosis in 352 relevance to the pathophysiology in young CAD patients. The genes chosen for the current study 353 were previously reported to be associated with CAD in other populations. Polymorphisms of some 354 of these genes were found to be associated with CAD earlier. Since cholesterol synthesis and 355 metabolism is arguably one of the most important processes involved in the manifestation of CAD, 356 we checked the methylation of a few genes involved in these processes. We observed that shown to harbor promoter hypermethylation in CAD patients of Chinese population. We also 376 found that APOC3 and APOA5 showed differential methylation in promoter and exonic region, Conclusions: 442 In this study, we observed that in CAD patients HMGCR and GALNT2 genes were 443 hypermethylated in the promoter indicating that cholesterol biosynthesis might be low. Besides,
444
LDLR receptor showed promoter hypomethylation and exonic hypermethylation indicating that 445 intracellular cholesterol uptake might be higher resulting in low plasma LDL-C levels. Low
446
APOC3 and higher APOA5 levels also reinforce our presumptions. Genes involved in endothelial 447 dysfunction and inflammation showed differential methylation in CAD patients. Endothelial NOS3 448 gene showed hypermethylation in promoter. These observations point towards the fact that genes 449 involved in processes like cholesterol metabolism, hyperglycemia induced endothelial 450 dysfunction, inflammation, extracellular matrix remodeling and platelet aggregation harbor 451 significant methylation signatures that need further validation in large prospective cohorts. This 452 study is also unique since it has investigated several genes whose methylation status has not been 453 investigated earlier in CAD patients of any other population. This study also highlights the 454 importance of methylation in the CDKN2A/CDKN2B cluster whose methylation status has not 455 been very well established. It also forms the basis for further investigation into the functional role 456 of these altered methylated genes in relation to CAD pathogenesis. Our study has investigated 457 genes linked to important pathological processes involved with CAD majorly cholesterol 458 homeostasis, endothelial dysfunction, vasoconstriction, endothelial apoptosis and inflammation. 459 We have also highlighted that DNA methylation at candidate genes belonging to these processes 460 can be interrogated as epigenetic biomarkers of CAD. Figure 3B shows bioanalyzer profile of adapter ligated library with an average size of 250-280 bp. Figure 3C shows bioanalyzer profile of indexed library with an average size of 300 bp.
